Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells
Itziar Echeverria, Alexander Pereboev, Leyre Silva, Aintzane Zabaleta, José Ignacio Riezu‐Boj, Marta Bes, María Cubero, Francisco Borras‐Cuesta, Juan José Lasarte, Juan Ignacio Esteban, Jesús Prieto, Pablo Sarobe – 30 March 2011 – Injection of dendritic cells (DCs) presenting viral proteins constitutes a promising approach to stimulate T cell immunity against hepatitis C virus (HCV). Here we describe a strategy to enhance antigen loading and immunostimulatory functions of DCs useful in the preparation of therapeutic vaccines.